Advance Agrolife Limited has confirmed that none of its promoters and promoter group, along with persons acting in concert, have created any encumbrance on the shares held by them during the financial year ended March 31, 2026. The disclosure ensures that the shareholding of the key stakeholders remains free from charges or pledges, providing stability to the company's ownership structure.

The confirmation was submitted to BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was made by Om Prakash Choudhary on behalf of all promoters and the promoter group of the target company.

The disclosure explicitly states that no direct or indirect encumbrance has been made over the shares of Advance Agrolife Limited by the specified entities throughout FY26. This declaration is part of the company's regulatory compliance to maintain transparency regarding the shareholding patterns of its promoters.

The letter was addressed to the stock exchanges on April 6, 2026, and copies were forwarded to the Audit Committee and the Company Secretary of Advance Agrolife Limited for their records and information.

Advance Agrolife Limited's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, at a meeting held on May 08, 2026. The statutory auditors, M/s S K Patodia & Associates LLP, issued an audit report with an unmodified opinion on the financial results. In compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the audited financial results as a newspaper advertisement in the Financial Express (English) and Business Remedies (Hindi regional) on May 09, 2026. The company also released an investor presentation detailing the performance, available on its website at www.advanceagrolife.com .

Financial Performance Overview

Advance Agrolife delivered a robust performance for the full year, with total revenue rising to ₹6,417.51 million from ₹5,028.76 million in the previous year, a growth of 28%. Net profit for the year grew to ₹352.84 million compared to ₹256.38 million previously, an increase of 38%. For the quarter ended March 31, 2026, total income stood at ₹1,259.07 million, up 40% year-on-year, with net profit surging 422% to ₹74.61 million versus ₹14.28 million. EBITDA for Q4 FY26 expanded significantly to ₹134 million from ₹57 million in the same quarter of the prior year, with the EBITDA margin improving to 10.82% from 6.35%, year-on-year. For the full year FY26, EBITDA stood at ₹639.90 million, up 34% over FY25, with an EBITDA margin of 9.99%, up 50 bps over the previous year. The following table summarises the key financial metrics:

Balance Sheet and Cash Flow Highlights

The company's total assets expanded significantly to ₹6,249.86 million as at March 31, 2026, compared to ₹3,514.72 million in the prior year. Total equity strengthened to ₹3,099.15 million from ₹1,008.73 million, supported by equity share capital of ₹642.86 million and other equity of ₹2,456.28 million. Inventories increased to ₹2,052.24 million from ₹876.08 million, while trade receivables rose to ₹1,962.41 million from ₹1,630.71 million. The balance sheet expansion reflects the company's ongoing investments in capacity and working capital to support revenue growth.

For the year ended March 31, 2026, net cash used in operating activities was ₹700.35 million, compared to net cash generated of ₹57.13 million in the prior year, primarily driven by a significant increase in inventories and trade receivables. Net cash used in investing activities stood at ₹1,076.70 million, reflecting investments in fixed assets and fixed deposits. Financing activities generated net cash of ₹1,825.81 million, supported by proceeds from the issue of shares and securities premium. Closing cash and cash equivalents for the year stood at ₹54.54 million, up from ₹5.77 million at the end of the previous year. The following table presents the key balance sheet figures:

Management Commentary

Commenting on the performance, Mr. Omprakash Choudhary, CMD, Advance Agrolife Limited, stated: "Advance Agrolife delivered a strong performance in FY26, and Q4 FY26 further indicates a stronger outlook ahead. Our financial performance for the year is the culmination of relentless efforts towards improving internal efficiencies, strengthening backward integration, expanding the customer base, and continuing to remain a strong and reliable partner to our marquee clients."

Strategic Developments and Expansion Plans

During the quarter, the company commenced production of Pretilachlor Technical and its intermediate PEDA (2,6-Diethyl-N-(2-propoxyethyl) Aniline) at its Manufacturing Facility I in Jaipur, with installed capacities of 5,000 MT p.a. and 3,700 MT p.a., respectively. CARE Ratings Limited upgraded the company's Long Term Bank Facilities of ₹1,008.90 million from BBB to BBB+. The company is also executing a 4x capacity expansion in 2,4-D herbicides, targeting production of 10,000 MT by Q4 FY28, and is evaluating the Dahej PCPIR cluster in Gujarat for this expansion to benefit from raw material proximity and potential pipeline access for key inputs. Additionally, the company aims to commence operations at its new Unit-4 technical manufacturing facility at Gidhani by Q2 FY27, with an estimated first-phase capital expenditure of approximately ₹250 million, which is expected to significantly enhance technical manufacturing capabilities. The company has also entered into a Memorandum of Understanding for the acquisition of land admeasuring 17,491.02 sq. mtrs. at Dahej II GIDC Industrial Estate, Bharuch, Gujarat, for setting up Unit-5, a proposed technical grade pesticides manufacturing plant.

The investor presentation highlighted the company's target to increase its export revenue share from approximately 2% currently to 20% by FY29, with a focus on regulated markets in Latin America and Southeast Asia, including Brazil. The company is also in the process of setting up a 3.75 MW solar power plant to increase renewable energy use and reduce its carbon footprint, with regulatory approvals currently under process. The following table summarises the key strategic initiatives and milestones:

Business Profile and Auditor Appointments

Advance Agrolife is a research-driven agrochemical manufacturer with a 20-year legacy in crop protection, operating as a pure-play B2B manufacturer for corporate customers. The company holds 410+ CIB & RC registrations (380 formulations and 30 technicals) and operates three integrated manufacturing facilities with an installed capacity of nearly 90,000 MTPA across Jaipur, Rajasthan. Its client base includes DCM Shriram, IFFCO, Mankind Agritech, HPM, Indogulf, Chambal Fertilisers, NFL, Zuari, and Matrix Fertiliser, with the top 10 customers contributing approximately 69% of revenue. The company has a presence in 19 states and 2 Union Territories domestically, and exports to 7 countries including UAE, Bangladesh, China, Turkey, Egypt, Kenya, and Nepal. As at March 31, 2026, the company had 64.3 million fully paid-up shares outstanding, with promoters holding 69.89%, DIIs holding 4.50%, and public shareholders holding 25.61%.

The board also re-appointed key audit professionals for the financial year 2026-27, as detailed below: